Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 2/20 | 0.71 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.71 |
| ▸ | PRKD2 | Q9BZL6 | 2/20 | 0.71 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3986232 | 1.00 | PRKD3 (0.71) | PRKD3PRKD1PRKD2HRH3MAPK14 | |
| SCHEMBL3986227 | 1.00 | PRKD3 (0.71) | PRKD3PRKD1PRKD2HRH3MAPK14 | |
| SCHEMBL4511344 | 0.92 | PRKD3 (0.74) | PRKD3PRKD1PRKD2HRH3CYP1A2 | |
| SCHEMBL4511350 | 0.92 | PRKD3 (0.74) | PRKD3PRKD1PRKD2HRH3CYP1A2 | |
| SCHEMBL4511341 | 0.92 | PRKD3 (0.74) | PRKD3PRKD1PRKD2HRH3CYP1A2 | |
| SCHEMBL4505550 | 0.91 | PRKD3 (0.64) | PRKD3PRKD1PRKD2HRH3CYP1A2 | |
| SCHEMBL4505545 | 0.91 | PRKD3 (0.64) | PRKD3PRKD1PRKD2HRH3CYP1A2 | |
| SCHEMBL4505555 | 0.91 | PRKD3 (0.64) | PRKD3PRKD1PRKD2HRH3CYP1A2 | |
| SCHEMBL4516758 | 0.91 | PRKD3 (0.68) | PRKD3PRKD1PRKD2HRH3MAPK14 | |
| SCHEMBL4516756 | 0.91 | PRKD3 (0.68) | PRKD3PRKD1PRKD2HRH3MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090247519-A1 | AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247519-A1 | AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE | PKD2, PKD1, AADAT | PRKD3 9/4885PRKD1 49/4885PRKD2 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.